I don't believe it will affect it to much on the basis that the announcement accompanying the raise info was extremely bullish - funds to fast track to phase II and commercialisation. In saying that cap. raises can lead to an initial decline - I wouldn't think it will be around long as the potential of the product is too high.
- Forums
- ASX - By Stock
- IBX
- Imagion Biosystems (ASX:IBX) enters trading halt ahead of breast cancer study
Imagion Biosystems (ASX:IBX) enters trading halt ahead of breast cancer study, page-6
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable